lactic acid has been researched along with clindamycin in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Calhoun, J; Cobos, J; Mader, JT | 1 |
| Heimrath, J; Hirnle, G; Hirnle, L; Kłósek, A; Małolepsza-Jarmołowska, K; Woytoń, J | 1 |
| Böttcher, T; Bunkowski, S; Christen, S; Gerber, J; Goiny, M; Kuhnt, U; Lotz, M; Lykkesfeldt, J; Nau, R; Ren, H; Schau, I; Spreer, A; Werner, C | 1 |
| Duewelhenke, N; Eysel, P; Krut, O | 1 |
| Ignjatović, N; Jančar, B; Maksin, T; Skapin, SD; Uskoković, D; Uskoković, V; Vukomanović, M | 1 |
| Ignjatović, N; Kralj, B; Poljanšek, I; Skapin, SD; Uskoković, D; Vukomanović, M; Zagar, E | 1 |
| Bračko, I; Ignjatović, N; Radmilović, V; Skapin, SD; Uskoković, D; Vukomanović, M; Zavašnik-Bergant, T | 1 |
| Heinsen, FA; Hellmig, S; Knecht, H; Koenen, ME; Ott, SJ; Rehman, A; Schreiber, S; Venema, K | 1 |
| Desai, TA; Hoover, C; Uskoković, DP; Uskoković, V; Vukomanović, M | 1 |
| Ashraf, W; Bayston, R; Blunn, GW; Cox, HC; Goodship, AE; McLaren, JS; Quirk, RA; Rahman, CV; Scammell, BE; Shakesheff, KM; White, LJ | 1 |
| Henslee, AM; Kasper, FK; Mikos, AG; Shah, SR; Wong, ME | 1 |
| da Silva, GR; de Almeida Vitor, RW; de L Gomes, EC; Fernandes-Cunha, GM; Fialho, SL; Goes, AM; Gomes, DA; Mussel, WN; Rezende, CM; Silva-Cunha, A; Yoshida, MI | 1 |
| Ashe, S; Das, NM; Nayak, B; Nayak, D; Rauta, PR | 1 |
| Behar-Cohen, F; da Silva, GR; Fernandes-Cunha, GM; Fialho, SL; Silva-Cunha, A; Zhao, M | 1 |
| Bhatia, K; Miller, ES; Young, DS | 1 |
| Barnabas, SL; Bekker, LG; Dabee, S; Dietrich, J; Froissart, R; Gamieldien, H; Gray, G; Happel, AU; Jaspan, HB; Jaumdally, SZ; Kullin, B; Passmore, JS; Wentzel, N; Zauchenberger, CZ | 1 |
1 trial(s) available for lactic acid and clindamycin
| Article | Year |
|---|---|
Exploring potential of vaginal Lactobacillus isolates from South African women for enhancing treatment for bacterial vaginosis.
Topics: Adolescent; Adult; Bacteroidaceae Infections; Clindamycin; Drug Resistance, Bacterial; Female; Gardnerella vaginalis; Gram-Positive Bacterial Infections; Humans; Hydrogen Peroxide; Lactic Acid; Lactobacillus; Metronidazole; Prevotella; South Africa; Species Specificity; Vaginosis, Bacterial | 2020 |
17 other study(ies) available for lactic acid and clindamycin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
In vitro evaluation of antibiotic diffusion from antibiotic-impregnated biodegradable beads and polymethylmethacrylate beads.
Topics: Anti-Bacterial Agents; Biodegradation, Environmental; Clindamycin; Delayed-Action Preparations; Diffusion; Drug Implants; Lactic Acid; Methylmethacrylates; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Tobramycin; Vancomycin | 1997 |
[Application of 2% clindamycin cream in the treatment of bacterial vaginosis and valuation of methylcellulose gel containing the complex of Chitosan F and PVP k-90 with lactic acid as carrier for intravaginally adhbited medicines in the cases of pregnanci
Topics: Administration, Intravaginal; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Chitin; Chitosan; Clindamycin; Female; Gels; Humans; Lactic Acid; Methylcellulose; Obstetric Labor, Premature; Ointments; Pharmaceutic Aids; Povidone; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Vaginosis, Bacterial | 2001 |
Clindamycin is neuroprotective in experimental Streptococcus pneumoniae meningitis compared with ceftriaxone.
Topics: Animals; Anti-Bacterial Agents; Body Temperature; Brain; Ceftriaxone; Cell Line, Tumor; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Clindamycin; Colony Count, Microbial; Glutamic Acid; Glycerol; Humans; Lactic Acid; Leukocyte Count; Lipid Peroxidation; Lipopolysaccharides; Male; Meningitis, Pneumococcal; Microdialysis; Neuroprotective Agents; Rabbits; Teichoic Acids; Tyrosine | 2004 |
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Poly(D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanospheres. Part 1: A multifunctional system for controlled drug delivery.
Topics: Adsorption; Ceramics; Chromatography, High Pressure Liquid; Clindamycin; Drug Delivery Systems; Humans; Hydroxyapatites; Lactic Acid; Materials Testing; Microscopy, Electron, Scanning; Nanospheres; Nanotechnology; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solvents; Surface Properties; Ultrasonics | 2011 |
Poly(D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanosphere. Part 2: Simultaneous release of a drug and a prodrug (clindamycin and clindamycin phosphate).
Topics: Adsorption; Anti-Bacterial Agents; Calorimetry; Chromatography, High Pressure Liquid; Clindamycin; Drug Delivery Systems; Humans; Hydroxyapatites; Lactic Acid; Materials Testing; Microscopy, Electron, Scanning; Nanospheres; Nanotechnology; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prodrugs; Surface Properties; Ultrasonics | 2011 |
Poly(D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanospheres. Part 3: properties of hydroxyapatite nano-rods and investigation of a distribution of the drug within the composite.
Topics: Adsorption; Clindamycin; Drug Carriers; Durapatite; Fluorescent Dyes; Lactic Acid; Materials Testing; Microscopy, Fluorescence; Nanospheres; Nanotubes; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spectroscopy, Fourier Transform Infrared; Surface Properties; Temperature | 2011 |
Effects of probiotics and antibiotics on the intestinal homeostasis in a computer controlled model of the large intestine.
Topics: Ammonia; Anti-Bacterial Agents; Clindamycin; Clostridium Infections; Fatty Acids, Volatile; Female; Homeostasis; Humans; Intestine, Large; Lactic Acid; Male; Metagenome; Middle Aged; Models, Biological; Probiotics | 2012 |
Osteogenic and antimicrobial nanoparticulate calcium phosphate and poly-(D,L-lactide-co-glycolide) powders for the treatment of osteomyelitis.
Topics: Animals; Anti-Infective Agents; Calcium Phosphates; Cell Line; Clindamycin; Collagen Type I; Core Binding Factor Alpha 1 Subunit; Hydrogen-Ion Concentration; Lactic Acid; Mice; Nanoparticles; Osteoblasts; Osteocalcin; Osteogenesis; Osteomyelitis; Osteopontin; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Staphylococcus aureus | 2013 |
A biodegradable antibiotic-impregnated scaffold to prevent osteomyelitis in a contaminated in vivo bone defect model.
Topics: Animals; Anti-Infective Agents; Biodegradable Plastics; Bone Regeneration; Clindamycin; Femur; Gentamicins; Guided Tissue Regeneration; Lactic Acid; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sheep; Staphylococcal Infections; Staphylococcus aureus; Tissue Scaffolds | 2014 |
Degradable, antibiotic releasing poly(propylene fumarate)-based constructs for craniofacial space maintenance applications.
Topics: Anti-Bacterial Agents; Carboxymethylcellulose Sodium; Clindamycin; Colistin; Face; Fumarates; Lactic Acid; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Molecular Weight; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polypropylenes; Porosity; Skull; Space Maintenance, Orthodontic; Tissue Scaffolds; X-Ray Microtomography | 2015 |
Anti-Toxoplasma activity and impact evaluation of lyophilization, hot molding process, and gamma-irradiation techniques on CLH-PLGA intravitreal implants.
Topics: Antiprotozoal Agents; Calorimetry, Differential Scanning; Cell Line; Clindamycin; Freeze Drying; Gamma Rays; Hot Temperature; Humans; Lactic Acid; Microscopy, Electron, Scanning; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectroscopy, Fourier Transform Infrared; Thermogravimetry; Toxoplasma; Vitreous Body; X-Ray Diffraction | 2016 |
Enhanced efficacy of clindamycin hydrochloride encapsulated in PLA/PLGA based nanoparticle system for oral delivery.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Physiological Phenomena; Cell Survival; Clindamycin; Delayed-Action Preparations; Diffusion; Drug Synergism; Lactic Acid; Nanocapsules; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2016 |
Ocular safety of Intravitreal Clindamycin Hydrochloride Released by PLGA Implants.
Topics: Animals; Biocompatible Materials; Cell Line; Clindamycin; Drug Delivery Systems; Ependymoglial Cells; Female; Humans; Interleukin-1beta; Interleukin-6; Intravitreal Injections; Lactic Acid; Macrophages; Microglia; Neuroglia; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostheses and Implants; Rats; Rats, Inbred Lew; Retina; Tumor Necrosis Factor-alpha; Vitreous Body | 2017 |
Fever and Malaise in an Infant.
Topics: Anti-Bacterial Agents; Antimalarials; Babesiosis; Clindamycin; Diagnosis, Differential; Doxycycline; Emergency Service, Hospital; Fever; Humans; Infant; Lactic Acid; Male; Quinine; Vomiting | 2017 |